Target intelligence / Profile preview

Keratin 8 pseudogene 50 (KRT8P50)

Target
KRT8P50
Molecular classification
Other, Pseudogene
01

Overview

Keratin 8 pseudogene 50 (KRT8P50) is a human type II keratin pseudogene. It is one of eight known type II keratin pseudogenes which lack protein-coding capacity and do not give rise to functional proteins[5]. As such, KRT8P50 does not play a direct biological role and is not a drug target, biomarker, or therapeutic candidate. Its presence is relevant only for gene annotation and nomenclature purposes. The closely related keratin 8 gene (KRT8), by contrast, encodes a type II cytoskeletal protein expressed in simple epithelia and is biologically and clinically significant[1][5][7]. However, KRT8P50 itself is not a functional gene. Key context: According to the revised mammalian keratin gene nomenclature, human keratin pseudogenes (both type I and II) are formally recognized but are numbered following the functional gene sets. There are currently 8 type II keratin pseudogenes of which KRT8P50 may be one, though full public entries specifically for KRT8P50 are sparse—it is not a major entity in clinical, pharmacological, or functional molecular databases[5]. Pseudogenes are generally transcribed non-coding gene fragments or relics of gene duplication events, and rarely (if ever) encode functional proteins in humans[5]. Keratin pseudogenes like KRT8P50 are important for gene annotation studies but do not function as molecular targets or disease-associated receptors/enzymes. If you meant the functional keratin 8 gene (KRT8), see [1][2][7] for details on its genuine biological roles and disease links. Summary: Keratin 8 pseudogene 50 (KRT8P50) is not a protein, target, or biological effector; it is a type II keratin pseudogene, included for completeness in keratin gene family references and does not have therapeutic or diagnostic value[5].

Other names
Keratin, type II cytoskeletal 8 pseudogene 50KRT8P50

Beyond the preview

Go deeper on Keratin 8 pseudogene 50 (KRT8P50).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 8 pseudogene 50 (KRT8P50).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call